Marine sponge derived natural products between 2001 and 2010: Trends and opportunities for discovery of bioactives

Marine Drugs

Volumn 12, Issue 8, 2014, Pages 4539-4577

  Mehbub, Mohammad Ferdous ^a,b   Lei, Jie ^a   Franco, Christopher ^a   Zhang, Wei ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b HAJEE MOHAMMAD DANESH SCIENCE AND TECHNOLOGY UNIVERSITY   (Bangladesh)

Author keywords

Anticancer; Bioactive compounds; Drug; Marine natural products; Marine sponges; Porifera; Sponge associated bacteria

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; 5 METHOXYAMPHIMEDINE; ALIPKINIDINE; ALKALOID DERIVATIVE; ANTINEOPLASTIC AGENT; BRENTUXIMAB VEDOTIN; CYCLOPEPTIDE; CYTARABINE; DISCODERMOLIDE; DOLASTATIN 10; ERIBULIN; FASCAPHYSIN; FATTY ACID DERIVATIVE; HALICHONDRIN B; HEMIASTERLIN A; HEMIASTERLIN B; ISOHOMOHALICHONDRIN B; LAULIMALIDE; NATURAL PRODUCT; PEPTIDE DERIVATIVE; PIPERAZINEDIONE; POLYKETIDE; PRODIGIOSIN; QUINONE DERIVATIVE; STEROID; TERPENE DERIVATIVE; TERPENOID DERIVATIVE; TRABECTEDIN; UNCLASSIFIED DRUG; VARIOLIN; BIOLOGICAL FACTOR; BIOLOGICAL PRODUCT;

AGELASIDA; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ASTROPHORIDA; AUSTRALIA; AXINELLIDA; BAHAMAS; CHINA; CHONDROSIDA; CHORISTIDA; CLATHRINIDA; CYTOTOXICITY; DENDROCERATIDA; DICTYOCERATIDA; DYSIDEA; HADROMERIDA; HALICHONDRIDA; HAPLOSCLERIDA; HOMOSCLEROPHORIDA; INDONESIA; IRCINIA; JAPAN; KOREA; LEUCOSOLENIDA; LITHISTIDA; LYSSACINOSIDA; MARINE SPECIES; MEXICO; NONHUMAN; OCILOSCLERIDA; PALAU; PAPUA NEW GUINEAN; PHILIPPINES; POECILOSCLERIDA; REVIEW; SPECIES DISTRIBUTION; SPECIES DIVERSITY; SPIROPHORIDA; SPONGE (PORIFERA); SYMBIOSIS; TAXONOMIC RANK; VANUATU; VERONGIDA; ANIMAL; CHEMISTRY; MARINE BIOLOGY; PROCEDURES;

ANIMALS; BIOLOGICAL FACTORS; BIOLOGICAL PRODUCTS; MARINE BIOLOGY; PORIFERA;

EID: 84908030259     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md12084539     Document Type: Review

References (197)

1. Bergmann, W.; Feeney, R. J. Contributions to the study of marine products. XXXII. The nucleosides of sponges I. J. Org. Chem. 1951, 16, 981-987.
2. Bergmann, W.; Feeney, R. J. The isolation of a new thymine pentoside from sponges 1. J. Am. Chem. Soc. 1950, 72, 2809-2810.
3. Carte, B. K. Biomedical potential of marine natural products. Bioscience 1996, 46, 271-287.
4. Burkholder, P. R.; Pfister, R. M.; Leitz, F. H. Production of a pyrrole antibiotic by a marine bacterium. Appl. Microbiol. 1966, 14, 649-653.
5. Proksch, P.; Edrada, R.; Ebel, R. Drugs from the seas-Current status and microbiological implications. Appl. Microbiol. Biotechnol. 2002, 59, 125-134.
6. Weinheimer, A. J.; Spraggins, R. L. The occurrence of two new prostaglandin derivatives (15-epi-PGA and its acetate, methyl ester) in the Gorgonian Plexaura homomalla chemistry of Coelenterates. XV. Tetrahedron Lett. 1969, 10, 5185-5188.
7. Ireland, C. M.; Copp, B. R.; Foster, M. P.; McDonald, L. A.; Radisky, D. C.; Swersey, J. C. Biomedical potential of marine natural products. In Pharmaceutical and Bioactive Natural Products; Springer: Berlin/Heidelberg, Germany, 1993; pp. 1-43.
8. Gordon, E. M.; Barrett, R. W.; Dower, W. J.; Fodor, S. P.; Gallop, M. A. Applications of combinatorial technologies to drug discovery.2. Combinatorial organic synthesis, library screening strategies, and future directions. J. Med. Chem. 1994, 37, 1385-1401.
9. Alonso, D.; Khalil, Z.; Satkunanthan, N.; Livett, B. Drugs from the sea: Conotoxins as drug leads for neuropathic pain and other neurological conditions. Mini Rev. Med. Chem. 2003, 3, 785-787.
10. Hu, G. P.; Yuan, J.; Sun, L.; She, Z. G.; Wu, J. H.; Lan, X. J.; Zhu, X.; Lin, Y. C.; Chen, S. P. Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar. Drugs 2011, 9, 514-525.
11. Faulkner, D. J. Marine natural products. Nat. Prod. Rep. 2000, 17, 7-55.
12. Faulkner, D. J. Marine natural products. Nat. Prod. Rep. 2002, 19, 1-48.
13. Blunt, J. W.; Copp, B. R.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 2006, 23, 26-78.
14. Blunt, J. W.; Copp, B. R.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 2010, 27, 165-237.
15. Blunt, J. W.; Copp, B. R.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 2011, 28, 196-268.
16. Blunt, J. W.; Copp, B. R.; Keyzers, R. A.; Munro, M. H. G.; Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 2012, 29, 144-222.
17. Blunt, J. W.; Copp, B. R.; Keyzers, R. A.; Munro, M. H. G.; Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 2013, 30, 237-323.
18. Blunt, J. W.; Copp, B. R.; Keyzers, R. A.; Munro, M. H. G.; Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 2014, 31, 160-258.
19. Laport, M.; Santos, O.; Muricy, G. Marine sponges: Potential sources of new antimicrobial drugs. Curr. Pharma. Biotechnol. 2009, 10, 86-105.
20. Blunt, J. W.; Copp, B. R.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 2005, 22, 15-61.
21. Sagar, S.; Kaur, M.; Minneman, K. P. Antiviral lead compounds from marine sponges. Mar. Drugs 2010, 8, 2619-2638.
22. Paul, V. J.; Ritson-Williams, R.; Sharp, K. Marine chemical ecology in benthic environments. Nat. Prod. Rep. 2011, 28, 345-387.
23. Molinski, T. F.; Dalisay, D. S.; Lievens, S. L.; Saludes, J. P. Drug development from marine natural products. Nat. Rev. Drug Discov. 2009, 8, 69-85.
24. Wijffels, R. H. Potential of sponges and microalgae for marine biotechnology. Trends Biotechnol. 2008, 26, 26-31.
25. Leal, M. C.; Puga, J.; Serôdio, J.; Gomes, N. C.; Calado, R. Trends in the discovery of new marine natural products from invertebrates over the last two decades-Where and what are we bioprospecting? PLoS One 2012, 7, e30580.
26. Blunt, J. W.; Copp, B. R.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 2003, 20, 1-48.
27. Blunt, J. W.; Copp, B. R.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 2004, 21, 1-49.
28. Blunt, J. W.; Copp, B. R.; Hu, W.-P.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 2008, 25, 35-94.
29. Blunt, J. W.; Copp, B. R.; Hu, W.-P.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 2009, 26, 170-244.
30. Blunt, J. W.; Copp, B. R.; Hu, W.-P.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 2007, 24, 31-86.
31. Hooper, J. N. Sponguide. Guide to Sponge Collection and Identification; Queensland Museum: Queensland, Australia, 2000.
32. Paul, V. J.; Puglisi, M. P. Chemical mediation of interactions among marine organisms. Nat. Prod. Rep. 2004, 21, 189-209.
33. Paul, V. J.; Puglisi, M. P.; Ritson-Williams, R. Marine chemical ecology. Nat. Prod. Rep. 2006, 23, 153-180.
34. McClintock, J. B.; Baker, B. J. Marine Chemical Ecology; CRC Press: Boca Raton, FL, USA, 2010; pp. 1-624.
35. Lee, Y. K.; Lee, J.-H.; Lee, H. K. Microbial symbiosis in marine sponges. J. Microbiol. 2001, 39, 254-264.
36. Jensen, P. R.; Fenical, W. Strategies for the discovery of secondary metabolites from marine bacteria: Ecological perspectives. Ann. Rev. Microbiol. 1994, 48, 559-584.
37. Bernan, V.; Greenstein, M.; Maiese, W. Marine microorganisms as a source of new natural products. Adv. Appl. Microbiol. 1997, 43, 57-90.
38. Haygood, M. G.; Schmidt, E. W.; Davidson, S. K.; Faulkner, D. J. Microbial symbionts of marine invertebrates: Opportunities for microbial biotechnology. J. Mol. Microbiol. Biotechnol. 1999, 1, 33-43.
39. Osinga, R.; Armstrong, E.; Burgess, J. G.; Hoffmann, F.; Reitner, J.; Schumann-Kindel, G. Sponge-Microbe associations and their importance for sponge bioprocess engineering. Hydrobiologia 2001, 461, 55-62.
40. Fusetani, N. Biofouling and antifouling. Nat. Prod. Rep. 2004, 21, 94-104.
41. Li, C.-W.; Chen, J.-Y.; Hua, T.-E. Precambrian sponges with cellular structures. Science 1998, 279, 879-882.
42. Hentschel, U.; Hopke, J.; Horn, M.; Friedrich, A. B.; Wagner, M.; Hacker, J.; Moore, B. S. Molecular evidence for a uniform microbial community in sponges from different oceans. Appl. Environ. Microbiol. 2002, 68, 4431-4440.
43. Selvin, J.; Shanmugha Priya, S.; Seghal Kiran, G.; Thangavelu, T.; Sapna Bai, N. Sponge-associated marine bacteria as indicators of heavy metal pollution. Microbiol. Res. 2009, 164, 352-363.
44. Wilkinson, C.; Fay, P. Nitrogen fixation in coral reef sponges with symbiotic cyanobacteria. Nature 1979, 279, 527-529.
45. Diaz, M. C.; Rutzler, K. Sponges: An essential component of Caribbean coral reefs. Bull. Mar. Sci. 2001, 69, 535-546.
46. Thoms, C.; Horn, M.; Wagner, M.; Hentschel, U.; Proksch, P. Monitoring microbial diversity and natural product profiles of the sponge Aplysina cavernicola following transplantation. Mar. Biol. 2003, 142, 685-692.
47. Thoms, C.; Schupp, P. Biotechnological potential of marine sponges and their associated bacteria as producers of new pharmaceuticals (Part II). J. Int. Biotechnol. Law 2005, 2, 257-264.
48. Proksch, P. Defensive roles for secondary metabolites from marine sponges and sponge-feeding nudibranchs. Toxicon 1994, 32, 639-655.
49. Pawlik, J. R.; McFall, G.; Zea, S. Does the odor from sponges of the genus Ircinia protect them from fish predators? J. Chem. Ecol. 2002, 28, 1103-1115.
50. Mahon, A. R.; Amsler, C. D.; McClintock, J. B.; Amsler, M. O.; Baker, B. J. Tissue-specific palatability and chemical defenses against macropredators and pathogens in the common articulate brachiopod Liothyrella uva from the Antarct. Penins. J. Exp. Mar. Biol. Ecol. 2003, 290, 197-210.
51. Paul, V.; Cruz-Rivera, E.; Thacker, R. Chemical mediation of macroalgal-herbivore interactions: Ecological and evolutionary perspectives. In Marine Chemical Ecology; CRC Press: Boca Raton, FL, USA, 2001; pp. 227-265.
52. Unson, M. D.; Holland, N. D.; Faulkner, D. J. A brominated secondary metabolite synthesized by the cyanobacterial symbiont of a marine sponge and accumulation of the crystalline metabolite in the sponge tissue. Mar. Biol. 1994, 119, 1-11.
53. Vacelet, J.; Vacelet, E.; Gaino, E.; Gallissian, M. Bacterial attack of spongin skeleton during the 1986-1990 Mediterranean sponge disease. In Sponges in Time and Space; Balkema: Rotterdam, The Netherlands, 1994; pp. 355-362.
54. Boehm, M.; Hentschel, U.; Friedrich, A.; Fieseler, L.; Steffen, R.; Gamulin, V.; Mueller, I.; Müller, W. Molecular response of the sponge Suberites domuncula to bacterial infection. Mar. Biol. 2001, 139, 1037-1045.
55. Maldonado, M.; Sánchez-Tocino, L.; Navarro, C. Recurrent disease outbreaks in corneous demosponges of the genus Ircinia: Epidemic incidence and defense mechanisms. Mar. Biol. 2010, 157, 1577-1590.
56. Selvin, J.; Ninawe, A.; Seghal Kiran, G.; Lipton, A. Sponge-microbial interactions: Ecological implications and bioprospecting avenues. Crit. Rev. Microbiol. 2010, 36, 82-90.
57. Thakur, N. L.; Müller, W. E. Biotechnological potential of marine sponges. Curr. Sci. 2004, 86, 1506-1512.
58. Tilvi, S.; Rodrigues, C.; Naik, C.; Parameswaran, P.; Wahidhulla, S. New bromotyrosine alkaloids from the marine sponge Psammaplysilla purpurea. Tetrahedron 2004, 60, 10207-10215.
59. Abad, M.; Bedoya, L.; Bermejo, P. Marine compounds and their antimicrobial activities. In Science Against Microbial Pathogens: Communicating Current Research and Technological Advances; Formatex Research Center: Badajoz, Spain, 2011.
60. Van Soest, R.; Boury-Esnault, N.; Hooper, J.; Rützler, K.; de Voogd, N.; Alvarez de Glasby, B.; Hajdu, E.; Pisera, A.; Manconi, R.; Schoenberg, C. World Porifera Database. The World Register of Marine Species (WoRMS). Available online: http://www.marinespecies.org/porifera (accessed on 25 October 2012).
61. Appeltans, W.; Decock, W.; Vanhoorne, B.; Hernandez, F.; Bouchet, P.; Boxshall, G.; Fauchald, K.; Gordon, D. P.; Poore, G. C. B.; van Soest, R.; et al. The World Register of Marine Species. In Proceedings of the future of the 21st century ocean: Marine Sciences and European Research Infrastructures, Brest, France, 28 June-1 July 2011; p. 30.
62. Ausubel, J.; Trew Christ, D.; Waggoner, P. First Census of Marine Life 2010: Highlights of A Decade of Discovery. Available online: http://www.coml.org/pressreleases/census2010/PDF/Highlights-2010-Report-Low-Res.pdf (accessed on 11 January 2014).
63. Valerie, P.; Raphael, R.-W. Marine chemical ecology. Nat. Prod. Rep. 2008, 25, 662-695.
64. Skropeta, D. Deep-sea natural products. Nat. Prod. Rep. 2008, 25, 1131-1166.
65. Faulkner, D. J. Marine natural products. Nat. Prod. Rep. 1998, 15, 113-158.
66. Crews, P.; Gerwick, W.; Schmitz, F.; France, D.; Bair, K.; Wright, A.; Hallock, Y. Molecular approaches to discover marine natural product anticancer leads-an update from a drug discovery group collaboration. Pharm. Biol. 2003, 41, 39-52.
67. Sipkema, D.; Franssen, M. C.; Osinga, R.; Tramper, J.; Wijffels, R. H. Marine sponges as pharmacy. Mar. Biotechnol. 2005, 7, 142-162.
68. Bhanot, A.; Sharma, R.; Noolvi, M. N. Natural sources as potential anti-cancer agents: A review. Int. J. Phytomed. 2011, 3, 9-26.
69. Newman, D. J.; Cragg, G. M. Marine natural products and related compounds in clinical and advanced preclinical trials. J. Nat. Prod. 2004, 67, 1216-1238.
70. Thakur, A. N.; Thakur, N. L.; Indap, M. M.; Pandit, R. A.; Datar, V. V.; Müller, W. E. Antiangiogenic, antimicrobial, and cytotoxic potential of sponge-associated bacteria. Mar. Biotechnol. 2005, 7, 245-252.
71. Cragg, G. M.; Newman, D. J.; Snader, K. M. Natural products in drug discovery and development. J. Nat. Prod. 1997, 60, 52-60.
72. Petit, K.; Biard, J.-F. Marine natural products and related compounds as anticancer agents: An overview of their clinical status. Anti-Cancer Agents Med. Chem. 2013, 13, 603-631.
73. Newman, D. J.; Cragg, G. M. Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development. Mar. Drugs 2014, 12, 255-278.
74. Kinghorn, A. D.; Chin, Y.-W.; Swanson, S. M. Discovery of natural product anticancer agents from biodiverse organisms. Curr. Opin. Drug Discov. Dev. 2009, 12, 189-196.
75. Duckworth, A. Farming sponges to supply bioactive metabolites and bath sponges: A review. Mar. Biotechnol. 2009, 11, 669-679.
76. Müller, W. E. G.; Böhm, M.; Batel, R.; de Rosa, S.; Tommonaro, G.; Müller, I. M.; Schröder, H. C. Application of cell culture for the production of bioactive compounds from sponges:? Synthesis of Avarol by primmorphs from Dysidea avara. J. Nat. Prod. 2000, 63, 1077-1081.
77. Zhang, X.; Cao, X.; Zhang, W.; Yu, X.; Jin, M. Primmorphs from archaeocytes-dominant cell population of the sponge Hymeniacidon perleve: Improved cell proliferation and spiculogenesis. Biotechnol. Bioeng. 2003, 84, 583-590.
78. Müller, W. E.; Grebenjuk, V. A.; le Pennec, G.; Schröder, H.-C.; Brümmer, F.; Hentschel, U.; Müller, I. M.; Breter, H.-J. Sustainable production of bioactive compounds by sponges-Cell culture and gene cluster approach: A review. Mar. Biotechnol. 2004, 6, 105-117.
79. Koopmans, M.; Martens, D.; Wijffels, R. H. Towards commercial production of sponge medicines. Mar. Drugs 2009, 7, 787-802.
80. Wilson, M. C.; Mori, T.; Rückert, C.; Uria, A. R.; Helf, M. J.; Takada, K.; Gernert, C.; Steffens, U. A.; Heycke, N.; Schmitt, S. An environmental bacterial taxon with a large and distinct metabolic repertoire. Nature 2014, 506, 58-62.
81. Jaspars, M.; Challis, G. Microbiology: A talented genus. Nature 2014, 506, 38-39.
82. Piel, J. Metabolites from symbiotic bacteria. Nat. Prod. Rep. 2004, 21, 519-538.
83. Van Soest, R. W.; Boury-Esnault, N.; Vacelet, J.; Dohrmann, M.; Erpenbeck, D.; de Voogd, N. J.; Santodomingo, N.; Vanhoorne, B.; Kelly, M.; Hooper, J. N. Global diversity of sponges (Porifera). PLoS One 2012, 7, e35105.
84. Kalaitzis, J. A. 2005. Chemical Investigations of Australian Marine Sponges. Available online: https://www120.secure.griffith.edu.au/rch/file/786c6d3d-925a-dea0-3864-2db686e40950/1/02 Chapter1.pdf (accessed on 29 April 2014).
85. Thomas, T. R. A.; Kavlekar, D. P.; LokaBharathi, P. A. Marine drugs from sponge-microbe association-A review. Mar. Drugs 2010, 8, 1417-1468.
86. Matsunaga, S.; Fusetani, N. Nonribosomal peptides from marine sponges. Curr. Org. Chem. 2003, 7, 945-966.
87. Matsunaga, S.; Fusetani, N.; Kato, Y.; Hirota, H. Aurantosides A and B: Cytotoxic tetramic acid glycosides from the marine sponge Theonella sp. J. Am. Chem. Soc. 1991, 113, 9690-9692.
88. Carmely, S.; Kashman, Y. Structure of swinholide-a, a new macrolide from the marine sponge Theonella swinhoei. Tetrahedron Lett. 1985, 26, 511-514.
89. Youssef, D. T.; Mooberry, S. L. Hurghadolide A and Swinholide I, potent actin-microfilament disrupters from the Red Sea sponge Theonella swinhoei. J. Nat. Prod. 2006, 69, 154-157.
90. Webster, N. S.; Blackall, L. L. What do we really know about sponge-microbial symbioses? Int. Soc. Micobial. Ecol. J. 2009, 3, 1-3.
91. Webster, N. S.; Taylor, M. W. Marine sponges and their microbial symbionts: Love and other relationships. Environ. Microbiol. 2012, 14, 335-346.
92. Mohamed, N. M.; Rao, V.; Hamann, M. T.; Kelly, M.; Hill, R. T. Monitoring bacterial diversity of the marine sponge Ircinia strobilina upon transfer into aquaculture. Appl. Environ. Microbiol. 2008, 74, 4133-4143.
93. Wilkinson, C. R. Net primary productivity in coral reef sponges. Science 1983, 219, 410-412.
94. Corredor, J. E.; Wilkinson, C. R.; Vicente, V. P.; Morell, J. M.; Otero, E. Nitrate release by Caribbean reef sponges. Limnol. Oceanogr. 1988, 33, 114-120.
95. Diaz, M. C.; Ward, B. B. Sponge-mediated nitrification in tropical benthic communities. Mar. Ecol. Prog. Ser. 1997, 156, 97-107.
96. Shieh, W. Y.; Lin, Y. M. Association of heterotrophic nitrogen-fixing bacteria with a marine sponge of Halichondria sp. Bull. Mar. Sci. 1994, 54, 557-564.
97. Wilkinson, C. C.; Summons, R. R.; Evans, E. Nitrogen fixation in symbiotic marine sponges: Ecological significance and difficulties in detection. Mem. Qld. Mus. 1999, 44, 667-673.
98. Hoffmann, F.; Larsen, O.; Thiel, V.; Rapp, H. T.; Pape, T.; Michaelis, W.; Reitner, J. An anaerobic world in sponges. Geomicrobiol. J. 2005, 22, 1-10.
99. Hentschel, U.; Fieseler, L.; Wehrl, M.; Gernert, C.; Steinert, M.; Hacker, J.; Horn, M. Microbial diversity of marine sponges. In Sponges (Porifera); Springer: Berlin/Heidelberg, Germany, 2003; pp. 59-88.
100. Kennedy, J.; Baker, P.; Piper, C.; Cotter, P. D.; Walsh, M.; Mooij, M. J.; Bourke, M. B.; Rea, M. C.; O'Connor, P. M.; Ross, R. P. Isolation and analysis of bacteria with antimicrobial activities from the marine sponge Haliclona simulans collected from Irish waters. Mar. Biotechnol. 2009, 11, 384-396.
101. Rahman, H.; Austin, B.; Mitchell, W. J.; Morris, P. C.; Jamieson, D. J.; Adams, D. R.; Spragg, A. M.; Schweizer, M. Novel anti-infective compounds from marine bacteria. Mar. Drugs 2010, 8, 498-518.
102. Lu, X.; Cao, X.; Liu, X.; Jiao, B. Marine microbes-derived anti-bacterial agents. Mini Rev. Med. Chem. 2010, 10, 1077-1090.
103. Dudler, R.; Eberl, L. Interactions between bacteria and eukaryotes via small molecules. Curr. Opin. Biotechnol. 2006, 17, 268-273.
104. Schmidt, E. W. Trading molecules and tracking targets in symbiotic interactions. Nat. Chem. Biol. 2008, 4, 466-473.
105. Hu, J.-F.; Hamann, M. T.; Hill, R.; Kelly, M. The manzamine alkaloids. Alkaloids Chem. Biol. 2003, 60, 207-285.
106. Jares-Erijman, E. A.; Sakai, R.; Rinehart, K. L. Crambescidins: New antiviral and cytotoxic compounds from the sponge Crambe crambe. J. Org. Chem. 1991, 56, 5712-5715.
107. ++ channel blocker activity of crambescidin 816. J. Nat. Prod. 1993, 56, 1007-1015.
108. Croué, J.; West, N. J.; Escande, M.-L.; Intertaglia, L.; Lebaron, P.; Suzuki, M. T. A single betaproteobacterium dominates the microbial community of the crambescidine-containing sponge Crambe crambe. Sci. Rep. 2013, 3, 1-8.
109. Sladic, D.; Gasic, M. J. Reactivity and biological activity of the marine sesquiterpene hydroquinone avarol and related compounds from sponges of the order Dictyoceratida. Molecules 2006, 11, 1-33.
110. Assmann, M.; Lichte, E.; Pawlik, J. R.; Köck, M. Chemical defenses of the Caribbean sponges Agelas wiedenmayeri and Agelas conifera. Mar. Ecol. Prog. Ser. 2000, 207, 255-262.
111. Neeman, I.; Fishelson, L.; Kashman, Y. Isolation of a new toxin from the sponge Latrunculia magnifica in the Gulf of Aquaba (Red Sea). Mar. Biol. 1975, 30, 293-296.
112. Keyzers, R. A.; Davies-Coleman, M. T. Anti-inflammatory metabolites from marine sponges. Chem. Soc. Rev. 2005, 34, 355-365.
113. Taylor, M. W.; Radax, R.; Steger, D.; Wagner, M. Sponge-associated microorganisms: Evolution, ecology, and biotechnological potential. Microbiol. Mol. Biol. Rev. 2007, 71, 295-347.
114. Dumdei, E. J.; Blunt, J. W.; Munro, M. H. G.; Battershill, C. N.; Page, M. J. The whys and whats of sponge chemistry: Why chemists extract sponges and what problems does this cause? In Sponge Sciences. Multidiscipinary Perspectives; Watanabe, Y., Fusetani, N., Eds.; Springer-Verlag: Tokyo, Japan, 1998; pp. 353-364.
115. Sacristán-Soriano, O.; Banaigs, B.; Casamayor, E. O.; Becerro, M. A. Exploring the links between natural products and bacterial assemblages in the sponge Aplysina aerophoba. Appl. Environ. Microbiol. 2011, 77, 862-870.
116. Rinehart, K. L. Secondary metabolites from marine organisms. Ciba Found. Symp. 1992, 171, 236-249.
117. Jenssen, H.; Hamill, P.; Hancock, R. E. Peptide antimicrobial agents. Clin. Microbiol. Rev. 2006, 19, 491-511.
118. Pasupuleti, M.; Schmidtchen, A.; Malmsten, M. Antimicrobial peptides: Key components of the innate immune system. Crit. Rev. Biotechnol. 2012, 32, 143-171.
119. Mohammed, R.; Peng, J.; Kelly, M.; Hamann, M. T. Cyclic heptapeptides from the Jamaican sponge Stylissa caribica. J. Nat. Prod. 2006, 69, 1739-1744.
120. Matsunaga, S.; Fusetani, N.; Konosu, S. Bioactive marine metabolites, IV. Isolation and the amino acid composition of discodermin A, an antimicrobial peptide, from the marine sponge Discodermia kiiensis. J. Nat. Prod. 1985, 48, 236-241.
121. Otero-González, A. J.; Magalhães, B. S.; Garcia-Villarino, M.; López-Abarrategui, C.; Sousa, D. A.; Dias, S. C.; Franco, O. L. Antimicrobial peptides from marine invertebrates as a new frontier for microbial infection control. FASEB J. 2010, 24, 1320-1334.
122. Pushpanathan, M.; Gunasekaran, P.; Rajendhran, J. Antimicrobial peptides: Versatile biological properties. Int. J. Pept. 2013, 2013, doi:10.1155/2013/675391.
123. Cooper, E. L. Comparative immunology. Integr. Comp. Biol. 2003, 43, 278-280.
124. Brogden, K. A. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005, 3, 238-250.
125. Langenheim, J. H. Higher plant terpenoids: A phytocentric overview of their ecological roles. J. Chem. Ecol. 1994, 20, 1223-1280.
126. Schmitz, F. J.; Bowden, B. F.; Toth, S. I. Antitumor and cytotoxic compounds from marine organisms. In Pharmaceutical and Bioactive Natural Products; Springer: Berlin/Heidelberg, Germany, 1993; pp. 197-308.
127. Zheng, L.; Yan, X.; Han, X.; Chen, H.; Lin, W.; Lee, F. S.; Wang, X. Identification of norharman as the cytotoxic compound produced by the sponge (Hymeniacidon perleve)-associated marine bacterium Pseudoalteromonas piscicida and its apoptotic effect on cancer cells. Biotechnol. Appl. Biochem. 2006, 44, 135-142.
128. Folmer, F.; Jaspars, M.; Dicato, M.; Diederich, M. Marine cytotoxins: Callers for the various dances of death. Gastroenterol. Hepatol. Bed Bench 2009, 2, S34-S50.
129. Bao, B.; Sun, Q.; Yao, X.; Hong, J.; Lee, C.-O.; Cho, H. Y.; Jung, J. H. Bisindole alkaloids of the topsentin and hamacanthin classes from a marine sponge Spongosorites sp. J. Nat. Prod. 2007, 70, 2-8.
130. Luo, X.; Li, F.; Hong, J.; Lee, C.-O.; Sim, C. J.; Im, K. S.; Jung, J. H. Cytotoxic oxylipins from a marine sponge Topsentia sp. J. Nat. Prod. 2006, 69, 567-571.
131. Mansoor, T. A.; Lee, Y. M.; Hong, J.; Lee, C.-O.; Im, K. S.; Jung, J. H. 5, 6:8, 9-Diepoxy and other cytotoxic sterols from the marine sponge Homaxinella sp. J. Nat. Prod. 2006, 69, 131-134.
132. Nagle, D. G.; Zhou, Y.-D.; Mora, F. D.; Mohammed, K. A.; Kim, Y.-P. Mechanism targeted discovery of antitumor marine natural products. Curr. Med. Chem. 2004, 11, 1725.
133. Aoki, S.; Cho, S.-H.; Ono, M.; Kuwano, T.; Nakao, S.; Kuwano, M.; Nakagawa, S.; Gao, J.-Q.; Mayumi, T.; Shibuya, M. Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells. Anti-Cancer Drugs 2006, 17, 269-278.
134. Singh, R.; Sharma, M.; Joshi, P.; Rawat, D. S. Clinical status of anti-cancer agents derived from marine sources. Anti-Cancer Agents Med. Chem. 2008, 8, 603-617.
135. Gong, H.; Zuliani, P.; Komuravelli, A.; Faeder, J. R.; Clarke, E. M. Analysis and verification of the HMGB1 signaling pathway. BMC Bioinform. 2010, 11, S10.
136. Essack, M.; Bajic, V. B.; Archer, J. A. Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment. Mar. Drugs 2011, 9, 1580-1606.
137. Valeriote, F. A.; Tenney, K.; Pietraszkiewicz, H.; Edelstein, M.; Johnson, T. A.; Amagata, T.; Crews, P. Discovery and development of anticancer agents from marine sponges: Perspectives based on a chemistry-experimental therapeutics collaborative program. J. Exp. Ther. Oncol. 2012, 10, 119-134.
138. Ford, P. W.; Gustafson, K. R.; McKee, T. C.; Shigematsu, N.; Maurizi, L. K.; Pannell, L. K.; Williams, D. E.; Dilip de Silva, E.; Lassota, P.; Allen, T. M. Papuamides AD, HIV-inhibitory and cytotoxic depsipeptides from the sponges Theonella mirabilis and Theonella swinhoei collected in Papua New Guinea. J. Am. Chem. Soc. 1999, 121, 5899-5909.
139. Qureshi, A.; Faulkner, D. J. Haplosamates A and B: New steroidal sulfamate esters from two haplosclerid sponges. Tetrahedron 1999, 55, 8323-8330.
140. Müller, W. E.; Sobel, C.; Diehl-Seifert, B.; Maidhof, A.; Schröder, H. C. Influence of the antileukemic and anti-human immunodeficiency virus agent avarol on selected immune responses in vitro and in vivo. Biochem. Pharmacol. 1987, 36, 1489-1494.
141. Zhou, X.; Liu, J.; Yang, B.; Lin, X.; Yang, X.-W.; Liu, Y. Marine natural products with anti-HIV activities in the last decade. Curr. Med. Chem. 2013, 20, 953-973.
142. Aoki, S.; Watanabe, Y.; Sanagawa, M.; Setiawan, A.; Kotoku, N.; Kobayashi, M. Cortistatins A, B, C, and D, anti-angiogenic steroidal alkaloids, from the marine sponge Corticium simplex. J. Am. Chem. Soc. 2006, 128, 3148-3149.
143. Aoki, S.; Watanabe, Y.; Tanabe, D.; Arai, M.; Suna, H.; Miyamoto, K.; Tsujibo, H.; Tsujikawa, K.; Yamamoto, H.; Kobayashi, M. Structure-activity relationship and biological property of cortistatins, anti-angiogenic spongean steroidal alkaloids. Bioorg. Med. Chem. 2007, 15, 6758-6762.
144. Mousseau, G.; Clementz, M. A.; Bakeman, W. N.; Nagarsheth, N.; Cameron, M.; Shi, J.; Baran, P.; Fromentin, R.; Chomont, N.; Valente, S. T. An analog of the natural steroidal alkaloid cortistatin a potently suppresses tat-dependent hiv transcription. Cell Host Microbe 2012, 12, 97-108.
145. Andavan, G. S. B.; Lemmens-Gruber, R. Cyclodepsipeptides from marine sponges: Natural agents for drug research. Mar. Drugs 2010, 8, 810-834.
146. Shin, J.; Rho, J. R.; Seo, Y.; Lee, H. S.; Cho, K. W.; Sim, C. J. Sarcotragins A and B, new sesterterpenoid alkaloids from the sponge Sarcotragus sp. Tetrahedron Lett. 2001, 42, 3005-3007.
147. Santafé, G.; Paz, V.; Rodríguez, J.; Jiménez, C. Novel cytotoxic oxygenated C29 Sterols from the Colombian marine sponge Polymastia tenax. J. Nat. Prod. 2002, 65, 1161-1164.
148. Pattenden, G.; Wickramasinghe, W. A.; Bandaranayake, W. M. Benzylthiocrellidone, a novel thioether with strong UV A and B absorption from the Great Barrier Reef sponge Crella spinulata, (Poecilosclerida: Crellidae). Trends Comp. Biochem. Physiol. 2002, 9, 205-216.
149. Costantino, V.; Fattorusso, E.; Imperatore, C.; Mangoni, A. Ectyoceramide, the first natural hexofuranosylceramide from the marine sponge Ectyoplasia ferox. Eur. J. Org. Chem. 2003, 2003, 1433-1437.
150. Nakao, Y.; Kuo, J.; Yoshida, W. Y.; Kelly, M.; Scheuer, P. J. More Kapakahines from the marine Sponge Cribrochalina olemda. Org. Lett. 2003, 5, 1387-1390.
151. Volk, C. A.; Kčk, M. Viscosamine: The first naturally occurring trimeric 3-alkyl pyridinium alkaloid. Org. Lett. 2003, 5, 3567-3569.
152. Xu, X.-H.; Yao, G.-M.; Li, Y.-M.; Lu, J.-H.; Lin, C.-J.; Wang, X.; Kong, C.-H. 5-Fluorouracil derivatives from the sponge Phakellia fusca. J. Nat. Prod. 2003, 66, 285-288.
153. Costantino, V.; Fattorusso, E.; Imperatore, C.; Mangoni, A. Glycolipids from sponges.13.1 Clarhamnoside, the first rhamnosylated a-galactosylceramide from Agelas clathrodes. Improving spectral strategies for glycoconjugate structure determination. J. Org. Chem. 2004, 69, 1174-1179.
154. Cichewicz, R. H.; Valeriote, F. A.; Crews, P. Psymberin, a potent sponge-derived cytotoxin from Psammocinia distantly related to the pederin family. Org. Lett. 2004, 6, 1951-1954.
155. Berer, N.; Rudi, A.; Goldberg, I.; Benayahu, Y.; Kashman, Y. Callynormine A, a new marine cyclic peptide of a novel class. Org. Lett. 2004, 6, 2543-2545.
156. Warabi, K.; Hamada, T.; Nakao, Y.; Matsunaga, S.; Hirota, H.; van Soest, R. W. M.; Fusetani, N. Axinelloside A, an unprecedented highly sulfated lipopolysaccharide inhibiting telomerase, from the marine sponge, Axinella infundibula. J. Am. Chem. Soc. 2005, 127, 13262-13270.
157. Hamada, T.; Matsunaga, S.; Yano, G.; Fusetani, N. Polytheonamides A and B, highly cytotoxic, linear polypeptides with unprecedented structural features, from the marine sponge, Theonella swinhoei. J. Am. Chem. Soc. 2005, 127, 110-118.
158. Williams, D. E.; Austin, P.; Diaz-Marrero, A. R.; Soest, R. V.; Matainaho, T.; Roskelley, C. D.; Roberge, M.; Andersen, R. J. Neopetrosiamides, peptides from the marine sponge Neopetrosia sp. that inhibit amoeboid invasion by human tumor cells. Org. Lett. 2005, 7, 4173-4176.
159. Rogers, E. W.; Molinski, T. F. A cytotoxic carotenoid from the marine sponge Prianos osiros. J. Nat. Prod. 2005, 68, 450-452.
160. Emura, C.; Higuchi, R.; Miyamoto, T. Irciniasulfonic acid B, a novel taurine conjugated fatty acid derivative from a Japanese marine sponge, Ircinia sp. Tetrahedron 2006, 62, 5682-5685.
161. Tanaka, C.; Tanaka, J.; Bolland, R. F.; Marriott, G.; Higa, T. Seragamides A-F, new actin-targeting depsipeptides from the sponge Suberites japonicus Thiele. Tetrahedron 2006, 62, 3536-3542.
162. Fattorusso, E.; Romano, A.; Taglialatela-Scafati, O.; Bavestrello, G.; Bonelli, P.; Calcinai, B. Coelodiol and coeloic acid, ent-isocopalane diterpenes from the Indonesian sponge Coelocarteria cfr.singaporensis. Tetrahedron Lett. 2006, 47, 2197-2200.
163. Dai, J.; Liu, Y.; Zhou, Y.-D.; Nagle, D. G. Cytotoxic metabolites from an Indonesian sponge Lendenfeldia sp. J. Nat. Prod. 2007, 70, 1824-1826.
164. Antonov, A. S.; Kalinovsky, A. I.; Stonik, V. A.; Afiyatullov, S. S.; Aminin, D. L.; Dmitrenok, P. S.; Mollo, E.; Cimino, G. Isolation and structures of Erylosides from the Carribean sponge Erylus formosus. J. Nat. Prod. 2007, 70, 169-178.
165. Johnson, T. A.; Amagata, T.; Oliver, A. G.; Tenney, K.; Valeriote, F. A.; Crews, P. The unexpected isolation of CTP-431, a novel thiopyrone from the sponge Cacospongia mycofijiensis. J. Org. Chem. 2008, 73, 7255-7259.
166. Zampella, A.; Sepe, V.; Luciano, P.; Bellotta, F.; Monti, M. C.; D'Auria, M. V.; Jepsen, T.; Petek, S.; Adeline, M.-T. R. S.; Laprvte, O. Homophymine A, an anti-HIV cyclodepsipeptide from the sponge Homophymia sp. J. Org. Chem. 2008, 73, 5319-5327.
167. Tung, N. H.; Minh, C. V.; Ha, T. T.; Kiem, P. V.; Huong, H. T.; Dat, N. T.; Nhiem, N. X.; Tai, B. H.; Hyun, J.-H.; Kang, H.-K.; et al. C29 sterols with a cyclopropane ring at C-25 and 26 from the Vietnamese marine sponge Ianthella sp. and their anticancer properties. Bioorg. Med. Chem. Lett. 2009, 19, 4584-4588.
168. DiGirolamo, J. A.; Li, X.-C.; Jacob, M. R.; Clark, A. M.; Ferreira, D. Reversal of fluconazole resistance by sulfated sterols from the marine sponge Topsentia sp. J. Nat. Prod. 2009, 72, 1524-1528.
169. Salim, A. A.; Rae, J.; Fontaine, F.; Conte, M. M.; Khalil, Z.; Martin, S.; Parton, R. G.; Capon, R. J. Heterofibrins: Inhibitors of lipid droplet formation from a deep-water southern Australian marine sponge, Spongia (Heterofibria) sp. Org. Biomol. Chem. 2010, 8, 3188-3194.
170. Dai, J.; Sorribas, A.; Yoshida, W. Y.; Kelly, M.; Williams, P. G. Xestosaprols from the Indonesian marine sponge Xestospongia sp. J. Nat. Prod. 2010, 73, 1188-1191.
171. Plaza, A.; Keffer, J. L.; Lloyd, J. R.; Colin, P. L.; Bewley, C. A. Paltolides A-C, Anabaenopeptin-type peptides from the Palau sponge Theonella swinhoei. J. Nat. Prod. 2010, 73, 485-488.
172. Wei, X.; Nieves, K.; Rodríguez, A. D. Neopetrosiamine A, biologically active bis-piperidine alkaloid from the Caribbean sea sponge Neopetrosia proxima. Bioorg. Med. Chem. Lett. 2010, 20, 5905-5908.
173. Fan, G.; Li, Z.; Shen, S.; Zeng, Y.; Yang, Y.; Xu, M.; Bruhn, T.; Bruhn, H.; Morschhäuser, J.; Bringmann, G.; Lin, W. Baculiferins A-O, O-sulfated pyrrole alkaloids with anti-HIV-1 activity, from the Chinese marine sponge Iotrochota baculifera. Bioorg. Med. Chem. 2010, 18, 5466-5474.
174. Schmitt, S.; Hentschel, U.; Taylor, M. W. Deep sequencing reveals diversity and community structure of complex microbiota in five Mediterranean sponges. Hydrobiologia 2012, 687, 341-351.
175. Erwin, P. M.; López-Legentil, S.; González-Pech, R.; Turon, X. A specific mix of generalists: Bacterial symbionts in Mediterranean Ircinia spp. FEMS Microbiol. Ecol. 2012, 79, 619-637.
176. Thiel, V.; Leininger, S.; Schmaljohann, R.; Brümmer, F.; Imhoff, J. F. Sponge-specific bacterial associations of the Mediterranean sponge Chondrilla nucula (Demospongiae, Tetractinomorpha). Microb. Ecol. 2007, 54, 101-111.
177. Perdicaris, S.; Vlachogianni, T.; Valavanidis, A. Bioactive natural substances from marine sponges: New developments and prospects for future pharmaceuticals. Nat. Prod. Chem. Res. 2013, 1, 1-8.
178. Sabdono, A. Microbial symbionts in marine sponges: Marine natural product factory. J. Coast. Dev. 2011, 11, 57-61.
179. Laird, S.; Monagle, C.; Johnston, S. Queensland biodiscovery collaboration: The Griffith University AstraZeneca Partnership for natural product discovery: An access and benefit sharing case study. In An Access and Benefit Sharing Case Study; United Nations University, Institute of Advanced Studies: Yokohama, Japan, 2008.
180. Mittermeier, R. A.; Goettsch Mittermeier, C. Megadiversity: Earth's Biologically Wealthiest Nations. Megadiversity: Most Biological Rich Countries of the World; Cemex: San Pedro Garza García, Mexico, 1997.
181. Tolley, M. UNEP-WCMC World Conservation Monitoring Centre Website; UNEP: Cambridge, UK, 2011.
182. Butler, A. J.; Rees, T.; Beesley, P.; Bax, N. J. Marine biodiversity in the Australian region. PLoS One 2010, 5, e11831.
183. Hughes, T. P.; Bellwood, D. R.; Connolly, S. R. Biodiversity hotspots, centres of endemicity, and the conservation of coral reefs. Ecol. Lett. 2002, 5, 775-784.
184. Roberts, C. M.; McClean, C. J.; Veron, J. E.; Hawkins, J. P.; Allen, G. R.; McAllister, D. E.; Mittermeier, C. G.; Schueler, F. W.; Spalding, M.; Wells, F. Marine biodiversity hotspots and conservation priorities for tropical reefs. Science 2002, 295, 1280-1284.
185. Wernberg, T.; Russell, B. D.; Moore, P. J.; Ling, S. D.; Smale, D. A.; Campbell, A.; Coleman, M. A.; Steinberg, P. D.; Kendrick, G. A.; Connell, S. D. Impacts of climate change in a global hotspot for temperate marine biodiversity and ocean warming. J. Exp. Mar. Biol. Ecol. 2011, 400, 7-16.
186. Ward, T. M.; Sorokin, S. J.; Currie, D. R.; Rogers, P. J.; McLeay, L. J. Epifaunal assemblages of the eastern Great Australian Bight: Effectiveness of a benthic protection zone in representing regional biodiversity. Cont. Shelf Res. 2006, 26, 25-40.
187. Fromont, J.; Vanderklift, M. A.; Kendrick, G. A. Marine Sponges of the Dampier Archipelago, Western Australia: Patterns of Species Distributions, Abundance and Diversity; Springer: Berlin/Heidelberg, Germany, 2006; Volume 15, pp. 3731-3750.
188. Hooper, J.; Kennedy, J. A. Small-scale patterns of sponge biodiversity (Porifera) from the Sunshine Coast reefs, eastern Australia. Invertebr. Syst. 2002, 16, 637-653.
189. Hooper, J. N.; Kennedy, J. A.; Quinn, R. J. Biodiversity "hotspots", patterns of richness and endemism, and taxonomic affinities of tropical Australian sponges (Porifera). Biodivers. Conserv. 2002, 11, 851-885.
190. Heyward, A. A.; Fromont, J. J.; Schoenberg, C. C.; Colquhoun, J. J.; Radford, B. B.; Gomez, O. O. The sponge gardens of Ningaloo Reef, Western Australia. Open Mar. Biol. 2010, 4, 3-11.
191. Fromont, J.; Althaus, F.; McEnnulty, F. R.; Williams, A.; Salotti, M.; Gomez, O.; Gowlett-Holmes, K. Living on the edge: The sponge fauna of Australia's southwestern and northwestern deep continental margin. Hydrobiologia 2012, 687, 127-142.
192. Williams, A.; Althaus, F.; Dunstan, P. K.; Poore, G. C.; Bax, N. J.; Kloser, R. J.; McEnnulty, F. R. Scales of habitat heterogeneity and megabenthos biodiversity on an extensive Australian continental margin (100-1100 m depths). Mar. Ecol. 2010, 31, 222-236.
193. Evans-Illidge, E. A.; Logan, M.; Doyle, J.; Fromont, J.; Battershill, C. N.; Ericson, G.; Wolff, C. W.; Muirhead, A.; Kearns, P.; Abdo, D. Phylogeny drives large scale patterns in australian marine bioactivity and provides a new chemical ecology rationale for future biodiscovery. PLoS One 2013, 8, e73800.
194. Dayton, P. K.; Robilliard, G. A.; Paine, R. T.; Dayton, L. B. Biological accommodation in the benthic community at McMurdo Sound, Antarctica. Ecol. Monogr. 1974, 44, 105-128.
195. Haefner, B. Drugs from the deep: Marine natural products as drug candidates. Drug Discov. Today 2003, 8, 536-544.
196. Cárdenas, C. A.; Bell, J. J.; Davy, S. K.; Hoggard, M.; Taylor, M. W. Influence of environmental variation on symbiotic bacterial communities of two temperate sponges. FEMS Microbiol. Ecol. 2014, 88, 516-527.
197. Schmitt, S.; Tsai, P.; Bell, J.; Fromont, J.; Ilan, M.; Lindquist, N.; Perez, T.; Rodrigo, A.; Schupp, P. J.; Vacelet, J. Assessing the complex sponge microbiota: Core, variable and species-specific bacterial communities in marine sponges. Int. Soc. Micob. Ecol. J. 2012, 6, 564-576.